2 recruiting, 1 completed, 1 not yet recruiting. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Recruiting 2, Completed 1, Not yet recruiting 1 |
Follow Insomnia Disorder: new trials by email Literature Review of Insomnia Disorder trials Research Report on Insomnia Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia Sleep Hygiene Education, Melatonin IR, 3 mg, Melatonin IR, 5 mg - Insomnia, Insomnia Disorder | Phase 4 | Recruiting | University of Pennsylvania | 1200 | 2026-05-01 | 2026-09-16 |
| Compound Ciwujia Granules in the Treatment of Insomnia Compound Ciwujia Granules group, Estazolam, Compound Ciwujia Granules and estazolam - Insomnia Disorder | Phase 4 | Not yet recruiting | Hui Zhu | 1200 | 2026-01-01 | 2025-12-29 |
| Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease Daridorexant 50 mg, Placebo, Polysomnography - Alzheimer Disease, Insomnia Disorder | Phase 4 | Recruiting | University Hospital, Montpellier | 62 | 2024-03-13 | 2026-06-25 |
| A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia Daridorexant, Placebo - Insomnia Disorder, Nocturia | Phase 4 | Completed | Idorsia Pharmaceuticals Ltd. | 60 | 2023-02-16 | 2025-04-18 |
Sleep Initiation and Maintenance Disorders (4) · Alzheimer Disease (1) · Nocturia (1)
Dyssomnias (4) · Mental Disorders (4) · Nervous System Diseases (4) · Sleep Disorders, Intrinsic (4) · Sleep Wake Disorders (4) · Brain Diseases (1) · Central Nervous System Diseases (1) · Dementia (1) · Lower Urinary Tract Symptoms (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Tauopathies (1) · Urological Manifestations (1)
daridorexant (2) · Diphenhydramine (1) · Doxepin (1) · Estazolam (1) · Neuropsychological Tests (1) · Trazodone (1) · Zolpidem (1)
Hui Zhu (1) · Idorsia Pharmaceuticals Ltd. (1) · University Hospital, Montpellier (1) · University of Pennsylvania (1)
United States (2) · France (1) · Germany (1) · Spain (1)
Michael L Perlis, PhD (1) · Yves Dauvilliers, MD (1)